April 16, 2026
Dear Reader,
There are many faces of “zero risk”: Public health loves precision when using “data for action”. Yet, when TBE meets bureaucracy, precision tends to take a vacation. As we prepare the ninth edition of The TBE Book, the usual ritual unfolds: chasing national case numbers that should already be neatly tabulated. Most arrive in time, some late, some never at all—and for a few, the silence is understandable. (War zones have higher priorities than case definitions.) Still, one wonders why officials struggle with their simple Excel sheets, when ticks, at least, respect seasonal deadlines and stop their activity each year when temperatures drop.The deeper question is what those case numbers really mean. If an “area of risk” is any area in which infection probability exceeds zero, then nearly all of northern and central Europe plus Asia should shimmer red. Quantifying such a probability to result in a TBE incidence would require systematic testing, of every CNS inflammation, everywhere. Perhaps with the exception of Austria, no public health system attempts that, yet policy relies on these elegant fictions.
And so, as always, data lag behind biology. Edition 9 of The TBE Book—coming in May—will again have the latest case numbers available, and – as before – we will provide these numbers in the context of the ECDC risk definition for arboviruses.
We also cover TBE in dogs in Norway, one article you should not even read (but you may want to read my comment), an infographic reflecting tick-borne viral diseases, and literature updates on long COVID, HBV screening in Vietnam, high-dose influenza vaccine, a cell culture-based yellow fever vaccine, waning immunity with mpox and a meningococcal B outbreak in the UK. Finally, you can access our ViVa weekly news here.
Enjoy the reading!
With best wishes for your continued health, and receive the vaccine doses you need.
Warm regards,
Editor-in-Chief, Global Health Press
 |
Your go-to source for concise
updates on the latest developments in the world of vaccines. This week's VacciNEWS viewpoint: |
 |
Infographic of the weekVacciTUTOR is our CME-accredited online course dedicated to vaccines and vaccination. Developed by leading international researchers, the course offers over 60 comprehensive chapters covering fundamental topics such as microbiology and immunology, as well as detailed insights into vaccine-preventable diseases and their corresponding vaccines. Concise bullet-point summaries are available free of charge to support quick reference and learning. Feel free to download today’s tick-borne infectious diseases in humans infographic. » |
|
The TBE snapshotSnapshot week 16/2026: A Norwegian study (2016–2023) found 38% of dogs exposed to tick-borne pathogens, including TBE virus (19%). Exposure was highest in southern regions, reflecting rising human risk. Dogs serve as sentinel indicators for TBE circulation and potential human infection. |
 |
Early, deadly infection burden after CAR T – with product-specific risk patternsThis review highlights that a large FAERS database study shows infections after CAR-T therapy are common and can be serious, often occurring early after treatment. However, the analysis has major limitations—it mixes true infections with unclear diagnoses, lacks reliable data, and may overestimate risks. |
Be part of the Global Health Press Community - id-ea.org
Join our GHP community and access exclusive, subscriber-only articles, expert reviews, and in-depth features. By becoming a subscriber, you’ll stay ahead of the news with the latest vaccines and vaccination updates. Enjoy content designed specifically for our engaged audience.
We’re also excited to welcome contributors who share our passion for advancing the field of vaccines and vaccination,
public health and education. Whether it’s submitting an article, serving as a Country Editor, contributing research,
or hosting a webinar, there are many ways to get involved.
Become part of the conversation and strengthen global health together with us. Subscribe and join today!
Contact us at info@globalhealthpress.org to learn more.
| Let’s get the word out! : | |
 |
|
| Like what you read? Forward this email to your friends or colleagues. | |
| Invite your friends |
At Global Health Press Pte Ltd, we are committed to safeguarding your privacy.
Your contact details are never shared with third parties. If you no longer wish to receive updates from us, you can unsubscribe here.
Copyright © 2009-2026 Global Health Press Pte Ltd. Reg. No. 200921795N